Laura D. Locati

9.2k total citations · 2 hit papers
204 papers, 6.0k citations indexed

About

Laura D. Locati is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Laura D. Locati has authored 204 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Oncology, 81 papers in Surgery and 78 papers in Otorhinolaryngology. Recurrent topics in Laura D. Locati's work include Head and Neck Cancer Studies (76 papers), Salivary Gland Tumors Diagnosis and Treatment (49 papers) and Thyroid Cancer Diagnosis and Treatment (35 papers). Laura D. Locati is often cited by papers focused on Head and Neck Cancer Studies (76 papers), Salivary Gland Tumors Diagnosis and Treatment (49 papers) and Thyroid Cancer Diagnosis and Treatment (35 papers). Laura D. Locati collaborates with scholars based in Italy, United States and Netherlands. Laura D. Locati's co-authors include Lisa Licitra, Paolo Bossi, Cristiana Bergamini, Federica Perrone, Pasquale Quattrone, Cosimo Durante, Sophie Leboulleux, Kate Newbold, Marco Guzzo and Mauro Papotti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Laura D. Locati

190 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2019 730 citations Cosimo Durante, Sophie Leboulleux et al. Annals of Oncology profile →
High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

2006 507 citations Lisa Licitra, Federica Perrone et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura D. Locati Italy	38	2.9k	2.8k	1.8k	1.3k	1.1k	204	6.0k
Mark Zafereo United States	41	1.8k 0.6×	1.6k 0.6×	1.2k 0.7×	2.1k 1.6×	942 0.9×	192	4.9k
Kyung‐Ja Cho South Korea	38	1.9k 0.7×	1.3k 0.5×	999 0.5×	547 0.4×	946 0.9×	184	3.9k
Aleš Ryška Czechia	29	1.4k 0.5×	1.8k 0.6×	197 0.1×	526 0.4×	793 0.7×	189	3.6k
Shunji Takahashi Japan	44	910 0.3×	5.3k 1.9×	354 0.2×	688 0.5×	2.4k 2.2×	353	7.8k
Erich M. Sturgis United States	32	583 0.2×	1.2k 0.4×	567 0.3×	436 0.3×	673 0.6×	80	3.3k
John Th. M. Plukker Netherlands	50	4.7k 1.6×	2.5k 0.9×	185 0.1×	1.1k 0.9×	5.2k 4.7×	177	9.2k
F Démard France	36	1.4k 0.5×	2.4k 0.9×	1.3k 0.7×	105 0.1×	1.5k 1.4×	145	4.6k
Hyunseok Kang United States	28	1000 0.4×	2.0k 0.7×	1.0k 0.6×	86 0.1×	889 0.8×	102	3.4k
Alexandre Bozec France	29	1.1k 0.4×	845 0.3×	867 0.5×	216 0.2×	833 0.8×	158	2.9k
Mark Agulnik United States	36	782 0.3×	2.6k 0.9×	615 0.3×	97 0.1×	2.1k 1.9×	165	4.2k

Countries citing papers authored by Laura D. Locati

Since Specialization

Citations

This map shows the geographic impact of Laura D. Locati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura D. Locati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura D. Locati more than expected).

Fields of papers citing papers by Laura D. Locati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura D. Locati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura D. Locati. The network helps show where Laura D. Locati may publish in the future.

Co-authorship network of co-authors of Laura D. Locati

This figure shows the co-authorship network connecting the top 25 collaborators of Laura D. Locati. A scholar is included among the top collaborators of Laura D. Locati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura D. Locati. Laura D. Locati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leboulleux, Sophie, Laura Boucai, Naifa L. Busaidy, et al.. (2025). Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement. The Lancet Diabetes & Endocrinology. 13(6). 516–527. 1 indexed citations

Fermi, Matteo, et al.. (2025). Survival behavior of patients treated with curative and palliative electrochemotherapy for oral and oropharyngeal cancer: a systematic review. European Archives of Oto-Rhino-Laryngology.

Ciccone, Lucia Pia, Maria Bonora, Sara Ronchi, et al.. (2024). Charged particle radiotherapy for thyroid cancer. A systematic review. Critical Reviews in Oncology/Hematology. 202. 104463–104463.

Frascaroli, Mara, et al.. (2024). Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer: A Case Report. SHILAP Revista de lepidopterología. 11(2). 1–6.

Sottotetti, Federico, Alberto Malovini, Giulia Riva, et al.. (2024). Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosis. Clinical Nutrition ESPEN. 63. 585–594. 7 indexed citations

Locati, Laura D., Renata Ferrarotto, Lisa Licitra, et al.. (2023). Current management and future challenges in salivary glands cancer. Frontiers in Oncology. 13. 1264287–1264287. 11 indexed citations

Locati, Laura D., Elena Colombo, Marek Dedecjus, et al.. (2022). Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck Cancer Groups. European Journal of Cancer. 180. 146–154. 8 indexed citations

Cavalieri, Stefano, Paolo Bossi, Gabriele Infante, et al.. (2022). The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients. Cancers. 14(24). 6170–6170. 2 indexed citations

Cavalieri, Stefano, Cristiana Bergamini, Carlo Resteghini, et al.. (2021). Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies. SHILAP Revista de lepidopterología. 2(6). 522–542. 7 indexed citations

10.

Cavalieri, Stefano, Silvana Canevari, Ruud H. Brakenhoff, et al.. (2021). Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma. JCO Precision Oncology. 5(5). 1666–1676. 9 indexed citations

11.

Cavallo, Anna, Nicola Alessandro Iacovelli, T. Rancati, et al.. (2021). Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients. Cancers. 13(16). 3983–3983. 2 indexed citations

12.

Ripamonti, Carla B., Paolo Bossi, Siranoush Manoukian, et al.. (2021). Malignant salivary gland tumours in families with breast cancer susceptibility. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(1). 221–226. 1 indexed citations

13.

Giani, Carlotta, Laura Valerio, Alberto Bongiovanni, et al.. (2020). Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer. Thyroid. 31(2). 224–232. 33 indexed citations

14.

Locati, Laura D., Ester Orlandi, Carlo Resteghini, et al.. (2019). Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma. Cancers. 11(8). 1057–1057. 24 indexed citations

15.

Bossi, Paolo, Marco Siano, Cristiana Bergamini, et al.. (2017). Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?. Disease Markers. 2017. 1–9. 6 indexed citations

16.

Alfieri, Salvatore, Cristiana Bergamini, Roberta Granata, et al.. (2017). Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience. Targeted Oncology. 13(2). 253–256. 10 indexed citations

17.

Bossi, Paolo, Cristiana Bergamini, Marco Siano, et al.. (2016). Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab. Clinical Cancer Research. 22(15). 3961–3970. 53 indexed citations

18.

Licitra, Lisa, Federica Perrone, Elena Tamborini, et al.. (2011). Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients. Annals of Oncology. 22(8). 1886–1893. 28 indexed citations

19.

Guzzo, Marco, Laura D. Locati, Franz J. Prott, et al.. (2009). Major and minor salivary gland tumors. Critical Reviews in Oncology/Hematology. 74(2). 134–148. 382 indexed citations

20.

Schlumberger, Martin, Rossella Elisei, Lars Bastholt, et al.. (2009). Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer. Journal of Clinical Oncology. 27(23). 3794–3801. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact